Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 06/14/24 06:02:00 on US and Canada Markets.
2024-06-14 06:02:00 ET Why New Investors Should Look Into Investing in Penny Stocks Penny stocks offer an intriguing entry point for new investors looking to tap into the stock market without a substantial initial investment. These stocks, typically priced under $5, allow individuals to...
2024-06-14 06:02:00 ET Why New Investors Should Look Into Investing in Penny Stocks Penny stocks offer an intriguing entry point for new investors looking to tap into the stock market without a substantial initial investment. These stocks, typically priced under $5, allow individuals to...
2024-06-14 06:00:13 ET Mark Mahaney from Evercore ISI issued a price target of $75.00 for SHOP on 2024-06-14 04:59:00. The adjusted price target was set to $75.00. At the time of the announcement, SHOP was trading at $64.69. The overall price target consensus is at $86.0...
Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced that Forbes Alexander has been appointed to the Company’s Board of ...
– Observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete remission (CR)/marrow complete remission (mCR) rate of 58% and median overall survival had not yet been reached – – Observed 43% ORR in frontli...
STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer r...
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Eureka Lithium Corp. (CSE: ERKA) (OTCQB: UREKF) (FSE: S580) (" Eureka Lithium " or " Eureka " or the " Company ") announces that it intends to proceed with a share consolidation (the " Consolidation ") of its issued and outstanding...
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation Preliminary data suggest promising efficacy and tolerability Safety profile was consistent with results o...
2024-06-14 05:50:00 ET Novo Nordisk 's (NYSE: NVO) Wegovy currently reigns as the king of the obesity drug market. It generated roughly $4.5 billion in sales last year and will likely rake in even more in 2024. But note the use of the word "currently." Wegovy's market-topping po...
2024-06-14 05:50:00 ET Novo Nordisk 's (NYSE: NVO) Wegovy currently reigns as the king of the obesity drug market. It generated roughly $4.5 billion in sales last year and will likely rake in even more in 2024. But note the use of the word "currently." Wegovy's market-topping po...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.32%Change Percent:
Grom Social Enterprises Inc. Company Name:
GROM Stock Symbol:
NASDAQ Market:
gromsocial.com Website: